Results 1 - 8 of 8
See what the best CAPS players recommend now.
Actions speak louder than words.
A secondary stock offering that investors should be happy about.
Glaxo's Three-Quarter-Billion-Dollar Gamble
Glaxo adds another development stage drugmaker to its portfolio.
More Good News About Cancer Vaccines
Pfizer's deal with Avant for an immunotherapy for brain cancer is promising.
Maybe what glitters really is gold.
Some of our CAPS investors have already beaten the market with huge gains. See which promising companies they're looking at now.
7 Companies With the Urge to Merge
With merger-and-acquisition fever said to be waning, which deals will be the ones to work out?
Results 1 - 8 of 8
Legal Information © 1995 - 2008 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK